home.aspx
 
EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...

Aramark Healthcare

SHARESHARESHARE
Aramark's Healthcare team provides best-in-class support services that are essential to healthcare delivery. Understanding that clinical excellence and the environment are interdependent, Aramark directly impacts the entire healthcare continuum – patient, employee, nurse and physician satisfaction, operational efficiency and service excellence.
SHARESHARESHARE

RELATED NEWS


Paratek Pharmaceuticals, a biopharmaceutical company focused on tetracycline chemistry-based therapies, has completed the submission of two new drug applications (NDAs) to FDA for once-daily oral and intravenous (IV) formulations of omdacycline, its broad-specturm investigational antibiotic, the company announced on Feb. 5, 2018....
PHARMACEUTICAL TECHNOLOGY MAGAZINE
READ MORE

MSD has decided to pull the plug on its late-stage cholesterol drug anacetrapib after a lacklustre performance in clinical trials. The company said it would not file for approval of the investigational cholesteryl ester transfer protein (CETP) inhibitor on the back of a review of its clinical profile that included discussions with external experts....

READ MORE

It's been more than a year since then-president elect Donald Trump said pharma was "getting away with murder," blasting the industry's corporate lobbying power and calling for "competitive bidding" to reduce pharmaceutical prices. On Friday, in a promised speech delayed twice, the U.S. public finally has a chance to see how sincere he was. Not so much, if Friday morning chatter bears out. While on the campaign trail, candidate Trump crossed a party line and called for...
FIERCEPHARMA
READ MORE

Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious Diseases. The results are significant as public health experts have long warned that the parasite responsible for most malaria cases, Plasmodium falciparum, is developing resistance to widely used treatments....

READ MORE

Hospitals are dealing with a shortage of sodium bicarbonate, a drug whose active ingredient is essentially the same one that cooks know as baking soda. Healthcare providers, which need the drug for uses that include heart surgery and chemo, are having to ration it right now because of supply issues reported by its primary producers, Amphastar and Pfizer....

READ MORE

A UCLA-led research team has identified genetic processes involved in the neurodegeneration that occurs in dementia an important step on the path toward developing therapies that could slow or halt the course of the disease. The findings appear Dec. 3 in the journal Nature Medicine. The researchers discovered two major groups of genes involved in mutations that result in an overproduction of a protein called tau, a hallmark of the progressive loss of neurons seen in major forms of dementia. The ...

READ MORE

EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...